The chief executive of Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, has stepped down after three years following a series of strategic stumbles and legal and operational setbacks that sent its shares plummeting. David Pollard reports.
Read more
No comments:
Post a Comment